UTRS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 19:18):

Stats
Dagens volum	26 100.00
Gjennomsnittsvolum	2 595.00
Markedsverdi	8 879.00
EPS	$0 ( 2024-05-03 )
Neste inntjeningsdato	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-01	Cohen Daniel	Buy	0	Common Stock
2023-02-09	New Enterprise Associates 13 Lp	Buy	24 437 927	Common Stock
2023-02-09	Accelmed Partners Ii L.p.	Sell	0	Common Stock
2023-02-09	Geiger Uri	Buy	0	Common Stock
2023-01-02	Usen Todd	Buy	0

INSIDER POWER
100.00
Last 92 transactions
Buy: 38 540 336 \| Sell: 1 194 556

Minerva Surgical, Inc. Korrelasjon

10 Mest positive korrelasjoner
MOTS	0.918
LGVN	0.914
CYTO	0.912
PCSA	0.911
CNEY	0.909
KXIN	0.908
DXYN	0.907
CVAC	0.907
CNSP	0.905
BCAN	0.898

10 Mest negative korrelasjoner
STEP	-0.915
AMRB	-0.912
AGFS	-0.91
SYNH	-0.887
RNLC	-0.886
LWAC	-0.884
SGII	-0.881
CSWI	-0.879
BRIVU	-0.874
IMPP	-0.874

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Minerva Surgical, Inc. Økonomi

Annual	2022
Omsetning:	$50.29M
Bruttogevinst:	$27.24M (54.17 %)
EPS:	$-23.68

FY	2022
Omsetning:	$50.29M
Bruttogevinst:	$27.24M (54.17 %)
EPS:	$-23.68

FY	2021
Omsetning:	$52.10M
Bruttogevinst:	$30.52M (58.58 %)
EPS:	$-1.158

FY	2020
Omsetning:	$37.77M
Bruttogevinst:	$19.12M (50.62 %)
EPS:	$-1.090

Financial Reports:

No articles found.

Minerva Surgical, Inc.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.